| Cardiac Arrhythmias and Treatments | Lifetime | 27 | IT 1 | 99.87 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 43 | IT 1 | 99.84 |
| Cardiac pacing and defibrillation studies | Lifetime | 29 | IT 2 | 99.84 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 52 | IT 4 | 99.75 |
| COVID-19 and healthcare impacts | Lifetime | 269 | IT 32 | 96.22 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 302 | IT 27 | 98.54 |
| Cardiac Structural Anomalies and Repair | Lifetime | 488 | IT 18 | 98.58 |
| Cardiomyopathy and Myosin Studies | Lifetime | 390 | IT 23 | 97.88 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 904 | IT 58 | 97.78 |
| ECG Monitoring and Analysis | Lifetime | 408 | IT 18 | 96.17 |
| Cardiovascular Effects of Exercise | Lifetime | 896 | IT 73 | 95.61 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 658 | IT 49 | 94.55 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 2 | IT 1 | 99.94 |
| Cardiac Arrhythmias and Treatments | 2021-2025 | 3 | IT 1 | 99.93 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 3 | IT 2 | 99.87 |
| Cardiac electrophysiology and arrhythmias | 2021-2025 | 6 | IT 1 | 99.73 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 24 | IT 4 | 99.43 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 14 | IT 2 | 99.41 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 76 | IT 9 | 99.19 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 111 | IT 7 | 98.63 |
| COVID-19 and healthcare impacts | 2021-2025 | 248 | IT 23 | 95.45 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 177 | IT 12 | 96.61 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 212 | IT 21 | 97.14 |
| Heart Failure Treatment and Management | 2021-2025 | 251 | IT 22 | 97.00 |
| Acute Ischemic Stroke Management | 2021-2025 | 541 | IT 16 | 96.02 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 835 | IT 109 | 94.79 |
| Acute Myocardial Infarction Research | 2021-2025 | 604 | IT 61 | 93.21 |
| ECG Monitoring and Analysis | 2021-2025 | 387 | IT 12 | 87.68 |
| Cardiac Health and Mental Health | 2021-2025 | 879 | IT 47 | 82.02 |
| Wireless Body Area Networks | 2021-2025 | 657 | IT 41 | 77.20 |
| Telemedicine and Telehealth Implementation | 2021-2025 | 984 | IT 25 | 75.98 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 554 | IT 57 | 74.20 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 296 | IT 84 | 69.36 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 924 | IT 60 | 68.47 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 350 | IT 63 | 61.31 |
| Quality and Safety in Healthcare | 2021-2025 | 754 | IT 68 | 37.55 |
